Market evolution: Vitamin preparations (CN 300450) — 2015–2025

Introduction

This report analyses the trade dynamics of the European Union for vitamin preparations (Customs code 300450) over the period 2015–2025. The EU is a major global player in this market, characterised by a significant and growing trade surplus. The analysis focuses on the evolution of trade values, volumes, prices, partner concentration, and production patterns to identify the key structural shifts and strategic trends within the sector. The data reveals a narrative of robust export growth, evolving import dependencies, and a strategic increase in domestic production capacity.

1. A Strengthening Surplus Fueled by Export Volume Growth

The EU's trade position in vitamin preparations has strengthened considerably over the decade, driven predominantly by a strong expansion in export volumes. This section details how export growth has consistently outpaced that of imports, solidifying the EU's net exporter status.

Export growth outpaces import trends, widening the trade balance

Between 2015 and 2025, the EU's export value for CN 300450 increased by 31.2%, rising from approximately €950 million to €1.25 billion. This growth was powered by a substantial 43.4% increase in exported quantity (from 36,899 to 52,907 tonnes), which offset an 8.5% decline in the average export price. In contrast, while import value also grew (by 40.5%), this occurred alongside a sharp 38.3% contraction in imported quantity. Consequently, the average import price surged by 127.9%. These diverging trends resulted in the EU's trade surplus expanding by 29.5% to over €1.04 billion by 2025, underscoring a period of enhanced competitive strength in external markets.

Divergent partner dynamics drive value changes

The top destinations for EU exports saw mixed but generally positive trends. Russia remained the largest single market, with exports increasing by 65.0% to €265 million. Notably, exports to Brazil (+203%) and Argentina (+540.5%) surged, indicating growing penetration in South American markets. The United Kingdom and Switzerland, traditional partners, showed more modest growth (22.2%) or slight decline (-10.3%), respectively. On the import side, a dramatic shift occurred: while imports from traditional European partners like the UK (-79.3%) and Switzerland (-47.6%) collapsed, those from the United States (+660.6%) and China (+235%) soared. This points to a significant reconfiguration of the EU's supply sources for vitamin preparations.

2. Structural Reconfiguration: Partners, Specialisation, and Production

Beyond aggregate trade flows, the period saw profound structural changes. The landscape of key trading partners became more concentrated, the internal EU specialisation map shifted, and a dramatic expansion in domestic production capacity fundamentally altered the sector's outlook.

Import market concentration increased while export destinations remained diversified

The Herfindahl-Hirschman Index (HHI) for import value rose by 23.8%, from 2,623 to 3,246, indicating a significant increase in concentration. This aligns with the surge in imports from the US and China, making the EU more reliant on a smaller group of non-EU suppliers. In contrast, the export HHI saw a more modest increase of 16.3% but remained at a much lower level (733), confirming that EU exports are distributed across a wide array of destination markets, reducing vulnerability to single-market shocks.

Internal EU specialisation varies sharply across Member States

Analysis of Revealed Symmetric Comparative Advantage (RSCA) in 2025 shows clear leaders and laggards within the EU. Greece, Ireland, and Belgium exhibit strong specialisation (high RSCA) in exporting vitamin preparations. Conversely, countries like Malta, Cyprus, and Finland show negative specialisation, indicating they are net importers or have negligible production. This highlights the uneven distribution of pharmaceutical manufacturing capacity for vitamins within the single market.

Domestic production value expanded dramatically, surpassing trade

Perhaps the most striking trend is the tripling of the EU's domestic production value, which grew by 209.2% from €2.53 billion to €7.81 billion between the first and last available years. This growth in production outpaced the expansion of trade (both exports and imports), suggesting a strategic build-up of internal capacity. This massive increase likely underpins the EU's ability to drive export growth while also potentially displacing some imports, contributing to the improved trade balance.

3. Navigating Volatility and a Strategic Shift Toward Self-Sufficiency

While the EU's overall position strengthened, the market experienced notable volatility and witnessed a strategic shift in its relationship with global trade, characterised by reduced import reliance but also a declining propensity to export its production.

Specific bilateral trade relationships experienced significant price shocks

The volatility analysis reveals that several trade corridors were subject to extreme price movements. The most notable events were a 135% price shock in exports to Norway in 2017, and 134.1% and 43.2% price shocks in exports to Türkiye and Mexico, respectively, in 2023. These anomalies, with high abnormality scores, suggest one-off supply or demand dislocations, contract changes, or currency effects in those specific markets, rather than a broad systemic trend.

Net import reliance declined sharply, indicating greater autonomy

The EU's net import reliance (calculated as (Imports - Exports) / Production) improved markedly from -25.6% to -13.0%. A negative value signifies the EU is a net exporter. The less negative figure in 2025 means exports grew faster than imports relative to production, enhancing the sector's autonomy. This is a direct consequence of the combined effect of booming production and strong export growth.

Export propensity fell, suggesting a strategic pivot towards the domestic market

Despite strong absolute export growth, the EU's export propensity—the share of domestic production that is exported—fell by 52.7% from 29.5% to 13.9%. Trade intensity (total trade relative to production) also halved. This indicates that the phenomenal growth in domestic production was primarily absorbed by the EU's internal market or used to replace imports, rather than being predominantly channelled into exports. It points to a strategic orientation towards greater self-sufficiency and catering to internal demand.

Conclusion

Over the 2015–2025 period, the EU's market for vitamin preparations (CN 300450) underwent a significant transformation. The bloc consolidated its position as a major net exporter, with its trade surplus growing by nearly 30%. This was achieved through volume-driven export expansion to diversified markets, most notably in Latin America and Russia. A major structural shift involved a dramatic reorientation of import sources away from European neighbours toward the United States and China, increasing import concentration.

The most transformative development, however, has been the massive expansion of EU domestic production capacity, which tripled in value. This underpinned the improved trade balance but, crucially, was largely channelled to serve the internal market. This is evidenced by the sharp decline in both export and trade propensities. Consequently, the EU has moved towards greater strategic autonomy in this sector, reducing its net import reliance while simultaneously strengthening its export base. The period thus reflects a successful strategy of import substitution and robust export growth, built on a foundation of substantially expanded domestic manufacturing.